Stay updated with breaking news from Nasdaq Gnom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Rating) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 102,800 shares, a growth of 139.6% from the March 15th total of 42,900 shares. Based on an average trading volume of 95,400 shares, the […]
Portland Global Advisors LLC lifted its holdings in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Rating) by 2.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 216,133 shares of the company’s stock after buying an additional 5,093 […]
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Rating) was the target of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 39,600 shares, a decline of 44.2% from the April 30th total of 71,000 shares. Based on an average daily volume of […]
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Rating) was the recipient of a large decrease in short interest in May. As of May 15th, there was short interest totalling 39,600 shares, a decrease of 44.2% from the April 30th total of 71,000 shares. Based on an average daily volume of 179,700 shares, the […]
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Rating) saw a significant growth in short interest in April. As of April 30th, there was short interest totalling 71,000 shares, a growth of 30.3% from the April 15th total of 54,500 shares. Based on an average daily volume of 100,600 shares, the short-interest ratio is […]